首页> 外文期刊>Biotechnology and Applied Biochemistry >Affibody molecule-mediated depletion of HSA and IgG using different buffer compositions: A 15 min protocol for parallel processing of 1-48 samples
【24h】

Affibody molecule-mediated depletion of HSA and IgG using different buffer compositions: A 15 min protocol for parallel processing of 1-48 samples

机译:Affibody分子介导的使用不同缓冲液成分的HSA和IgG耗竭:15分钟操作规程,可并行处理1-48个样品

获取原文
获取原文并翻译 | 示例
           

摘要

High-abundant plasma proteins pose a challenge in a large number of proteomics-based technologies. Depletion of these high-abundant proteins has proven to be a fruitful strategy to circumventmasking of lower-abundant proteins that could serve as valuable biomarker candidates. However, current strategies often do not meet the throughput requirements of largescale proteomic studies. In the present paper, a flexible and parallelized method for the depletion of high-abundant proteins is described, allowing the removal of the two most abundant proteins from 48 blood-derived samples in less than 15 min using Affibody molecules as affinity ligands. A sample-processing platform like this should be suitable for a number of proteomics technologies; its flexibility in buffer composition allows for different types of downstream applications.
机译:高蛋白血浆蛋白在众多基于蛋白质组学的技术中提出了挑战。这些高丰度蛋白质的消耗已被证明是规避可能用作有价值的生物标志物的较低丰度蛋白质的有效策略。但是,当前的策略通常不能满足大规模蛋白质组学研究的通量要求。在本文中,描述了一种灵活而并行的消耗高丰度蛋白质的方法,该方法允许使用Affibody分子作为亲和配体在不到15分钟的时间内从48个血液来源的样品中去除两种最丰富的蛋白质。这样的样品处理平台应适用于多种蛋白质组学技术。它在缓冲液成分上的灵活性允许用于不同类型的下游应用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号